Delivery Order SPE2DB25D3012-SPE2DB25FWZHB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,976.65 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 mL syringes. This firm fixed-price, competitively awarded contract—with no set-aside designation—calls for delivery of the pharmaceutical product to the company's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. LEQVIO is a prescription medication used to treat high cholesterol in patients at risk for cardiovascular...
- This delivery order, awarded August 4, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides LEQVIO 284 mg/1.5 mL syringes valued at $9.3K with a completion date of August 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, reflecting open and competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency Troop Support Medical awarded a $13,018.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562313798 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 26, 2023 through October 18, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and...
- The Defense Logistics Agency Troop Support Medical awarded a $8,679.24 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562342128 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price arrangement concluding in October 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen Drug Corp will deliver the requested LEQVIO injectable medication to support the Defense Logistics...
- The Defense Logistics Agency Troop Support Medical awarded a $13,018.86 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562055006 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to its place of performance in Conshohocken, Pennsylvania under firm fixed pricing by September 26, 2023. The contract supports the Defense Logistics Agency's mission to provide medical supplies to the U.S....
- The Defense Logistics Agency awarded a $4,339.64 delivery order to Amerisourcebergen Drug Corporation for 4561890439 LEQVIO 284 MG/1.5 ML SYRINGES. The firm fixed price order is for 1.5 ml syringes of LEQVIO to be delivered to a location in Conshohocken, Pennsylvania between August 21, 2023 and September 12, 2023. As a major component of the Department of Defense supply chain, the Defense Logistics Agency utilizes contracts such as this to procure necessary pharmaceutical and medical supplies...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor, to provide a specialty medication called LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The delivery order has a ceiling value of $2,197.41 and a completion date of May 3, 2024. It is not associated with any set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken,...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a Firm Fixed Price pricing type and a ceiling value of $4,651.10, with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and this award is associated with a larger Indefinite...
- This is a $2,197.41 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a prescription medication. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency awarded a delivery order valued at approximately $2,170 to Amerisourcebergen Drug Corporation for the provision of 4561569560 LEQVIO 284 MG/1.5 ML SYRINGES totaling 1.5 ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The firm fixed price order has a period of performance starting on July 21, 2023 and concluding on August 11, 2023. No subcontractors or set aside designations were identified. The Defense...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZHBDelivery Order
The Defense Logistics Agency awarded a $23,255.50 delivery order to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on August 18, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at the contractor's location in Conshohocken, Pennsylvania. LEQVIO is an injectable cardiovascular medication used to lower LDL cholesterol levels, reflecting the Defense Logistics Agency's ongoing need to supply specialized pharmaceutical products to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's extensive experience fulfilling federal medical supply requirements through open competition demonstrates its capability to meet the Defense Logistics Agency's comprehensive pharmaceutical support needs for military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.3k | 8/18/25 |